Lv2
105 积分 2021-05-03 加入
Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
20天前
已完结
Topiroxostat—A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review
21天前
已关闭
Global Epidemiology of Hyperuricemia: An Analysis of Trends Over the Past Decade
21天前
已完结
The cytokine CSBF inhibits the IL-17A and TNF-α inflammatory pathways via SUSD2-ACT1 in keratinocytes and alleviates IMQ-induced psoriasis
2个月前
已完结
Parenteral nutrition consensus report from KEPAN
4个月前
已完结
Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database
4个月前
已完结
皖公网安备34019202002308
